JP2013542185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542185A5 JP2013542185A5 JP2013528356A JP2013528356A JP2013542185A5 JP 2013542185 A5 JP2013542185 A5 JP 2013542185A5 JP 2013528356 A JP2013528356 A JP 2013528356A JP 2013528356 A JP2013528356 A JP 2013528356A JP 2013542185 A5 JP2013542185 A5 JP 2013542185A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- polypeptide
- transcription
- factor
- high mobility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38137710P | 2010-09-09 | 2010-09-09 | |
| US61/381,377 | 2010-09-09 | ||
| PCT/US2011/051107 WO2012034090A1 (en) | 2010-09-09 | 2011-09-09 | Compositions and methods for the removal of biofilms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015193476A Division JP2016000760A (ja) | 2010-09-09 | 2015-09-30 | バイオフィルムを除去するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542185A JP2013542185A (ja) | 2013-11-21 |
| JP2013542185A5 true JP2013542185A5 (enExample) | 2014-09-25 |
| JP6012603B2 JP6012603B2 (ja) | 2016-10-25 |
Family
ID=44654515
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013528356A Active JP6012603B2 (ja) | 2010-09-09 | 2011-09-09 | バイオフィルムを除去するための組成物および方法 |
| JP2015193476A Withdrawn JP2016000760A (ja) | 2010-09-09 | 2015-09-30 | バイオフィルムを除去するための組成物および方法 |
| JP2017122250A Active JP6420417B2 (ja) | 2010-09-09 | 2017-06-22 | バイオフィルムを除去するための組成物および方法 |
| JP2018081136A Withdrawn JP2018111731A (ja) | 2010-09-09 | 2018-04-20 | バイオフィルムを除去するための組成物および方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015193476A Withdrawn JP2016000760A (ja) | 2010-09-09 | 2015-09-30 | バイオフィルムを除去するための組成物および方法 |
| JP2017122250A Active JP6420417B2 (ja) | 2010-09-09 | 2017-06-22 | バイオフィルムを除去するための組成物および方法 |
| JP2018081136A Withdrawn JP2018111731A (ja) | 2010-09-09 | 2018-04-20 | バイオフィルムを除去するための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20120128701A1 (enExample) |
| EP (1) | EP2613797B1 (enExample) |
| JP (4) | JP6012603B2 (enExample) |
| AU (1) | AU2011299025B2 (enExample) |
| CA (1) | CA2810851C (enExample) |
| WO (1) | WO2012034090A1 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9457077B2 (en) | 2009-11-18 | 2016-10-04 | Katherine Rose Kovarik | Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases |
| US9585920B2 (en) | 2011-02-04 | 2017-03-07 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| WO2011123396A1 (en) * | 2010-03-29 | 2011-10-06 | University Of Southern California | Compositions and methods for the removal of biofilms |
| JP6012603B2 (ja) | 2010-09-09 | 2016-10-25 | ユニバーシティー オブ サザン カリフォルニア | バイオフィルムを除去するための組成物および方法 |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US10314865B2 (en) | 2011-02-04 | 2019-06-11 | Katherine Rose Kovarik | Method and system for treating cancer and other age-related diseases by extending the healthspan of a human |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| US10940169B2 (en) | 2015-11-30 | 2021-03-09 | Joseph E. Kovarik | Method for reducing the likelihood of developing cancer in an individual human being |
| US12533312B2 (en) | 2011-02-04 | 2026-01-27 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US11274144B2 (en) | 2013-06-13 | 2022-03-15 | Research Institute At Nationwide Children's Hospital | Compositions and methods for the removal of biofilms |
| EP3008088B1 (en) * | 2013-06-13 | 2019-08-21 | Research Institute at Nationwide Children's Hospital | Compositions and methods for the treatment of burkholderia infections |
| US9745366B2 (en) | 2013-09-23 | 2017-08-29 | University Of Southern California | Compositions and methods for the prevention of microbial infections |
| US10233234B2 (en) | 2014-01-13 | 2019-03-19 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| US11248040B2 (en) | 2013-09-26 | 2022-02-15 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11026982B2 (en) | 2015-11-30 | 2021-06-08 | Joseph E. Kovarik | Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11672835B2 (en) | 2013-12-20 | 2023-06-13 | Seed Health, Inc. | Method for treating individuals having cancer and who are receiving cancer immunotherapy |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11642382B2 (en) | 2013-12-20 | 2023-05-09 | Seed Health, Inc. | Method for treating an individual suffering from bladder cancer |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11529379B2 (en) | 2013-12-20 | 2022-12-20 | Seed Health, Inc. | Method and system for reducing the likelihood of developing colorectal cancer in an individual human being |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11213552B2 (en) | 2015-11-30 | 2022-01-04 | Joseph E. Kovarik | Method for treating an individual suffering from a chronic infectious disease and cancer |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| EP3536168A3 (en) | 2014-03-06 | 2019-10-16 | The Research Institute at Nationwide Children's Hospital | Probiotic formulations and methods for use |
| US10624934B2 (en) | 2014-03-06 | 2020-04-21 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations |
| WO2016154491A1 (en) * | 2015-03-25 | 2016-09-29 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| EP3322408B1 (en) | 2015-07-14 | 2022-06-08 | The Research Institute at Nationwide Children's Hospital | Novel formulation for the elimination of cariogenic and opportunistic pathogens within the oral cavity |
| US10940204B2 (en) | 2015-07-31 | 2021-03-09 | Research Institute At Nationwide Children's Hospital | Peptides and antibodies for the removal of biofilms |
| EP3365027B1 (en) | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| EP3565589A1 (en) | 2017-01-04 | 2019-11-13 | Research Institute at Nationwide Children's Hospital | Dnabii vaccines and antibodies with enhanced activity |
| AU2018206560B9 (en) | 2017-01-04 | 2025-04-03 | Research Institute At Nationwide Children's Hospital | Antibody fragments for the treatment of biofilm-related disorders |
| AU2018213671B2 (en) | 2017-01-27 | 2024-06-06 | Osaka University | Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure |
| EP3595445B1 (en) | 2017-03-15 | 2024-09-04 | The Research Institute at Nationwide Children's Hospital | Composition and methods for disruption of bacterial biofilms without accompanying inflammation |
| AU2018376452A1 (en) | 2017-12-01 | 2020-06-25 | Osaka University | Ectodermal mesenchymal stem cells and method for producing same |
| EP3718561A4 (en) | 2017-12-01 | 2021-07-21 | Stemrim Inc. | Therapy for inflammatory bowel disease |
| US20210024594A1 (en) | 2018-02-08 | 2021-01-28 | StemRIM Inc. | Therapeutic Agent for Psoriasis |
| JP6641420B2 (ja) | 2018-06-12 | 2020-02-05 | 株式会社アマダホールディングス | 分割金型の装着方法及びプレスブレーキ |
| WO2019241177A1 (en) * | 2018-06-12 | 2019-12-19 | Terumo Cardiovascular Systems Corporation | Circular retractor for cardiovascular valve procedures |
| US12304933B2 (en) | 2018-10-05 | 2025-05-20 | StemRIM Inc. | Disease treatment drug based on mesenchymal-stem-cell mobilization |
| JP2022504139A (ja) | 2018-10-05 | 2022-01-13 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | バイオフィルムの除去のためのｈｍｇｂ１タンパク質誘導体 |
| EP3870154A4 (en) | 2018-10-22 | 2022-07-27 | Research Institute at Nationwide Children's Hospital | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE |
| EP3930735A1 (en) | 2019-02-26 | 2022-01-05 | The Regents of the University of Colorado, a body corporate | Method and composition for treating gastrointestinal inflammatory disorders |
| KR102978329B1 (ko) | 2019-06-03 | 2026-06-17 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 패혈증 및 괴사성 장염 유도된 신경발달 결핍의 예방을 위한 프리바이오틱 제형 |
| CA3145385A1 (en) | 2019-07-08 | 2021-01-14 | Steven D. Goodman | Antibody compositions for disrupting biofilms |
| WO2025106896A1 (en) * | 2023-11-17 | 2025-05-22 | Rush University Medical Center | Coating of medical and implant biomaterials with an anti-biofilm agent to prevent and treat infection |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US20050131222A1 (en) | 1995-04-21 | 2005-06-16 | Human Genome Sciences, Inc. | Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| US6355450B1 (en) | 1995-04-21 | 2002-03-12 | Human Genome Sciences, Inc. | Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US20020042386A1 (en) * | 2000-01-31 | 2002-04-11 | Rosen Craig A. | Nucleic acids, proteins, and antibodies |
| WO2004001058A2 (en) | 2001-05-04 | 2003-12-31 | Paratek Pharmaceuticals, Inc. | Transcription factor modulating compounds and methods of use thereof |
| BR0209689A (pt) * | 2001-05-15 | 2006-02-07 | Long Island Jewish Res Inst | Uso de fragmento de hmg como agente anti-inflamatório |
| US8933029B2 (en) | 2001-08-24 | 2015-01-13 | Carrus Capital Corporation | Antimicrobial and anti-inflammatory peptides |
| ITMI20011986A1 (it) * | 2001-09-25 | 2003-03-25 | San Raffaele Centro Fond | Metodo e composizione per l'attivazione di cellule presentanti l'antigene |
| US20030099602A1 (en) | 2001-10-25 | 2003-05-29 | Levin Gilbert V. | D-tagatose as an anti-biofilm agent |
| CN1674933B (zh) | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| GB0226251D0 (en) * | 2002-11-11 | 2002-12-18 | San Raffaele Centro Fond | Acetylated protein |
| WO2004046338A2 (en) * | 2002-11-20 | 2004-06-03 | North Shore-Long Island Jewish Research Institute | Use of hmgb polypeptides for increasing immune responses |
| JP4754219B2 (ja) | 2002-12-02 | 2011-08-24 | アムジエン・フレモント・インコーポレイテツド | 腫瘍壊死因子を対象とする抗体、およびそれらの使用 |
| EP1579221A2 (de) * | 2003-01-03 | 2005-09-28 | Alcedo Biotech GmbH | Verwendungen von hmgb, hmgn, hmga proteinen |
| US7297340B2 (en) | 2003-01-07 | 2007-11-20 | University Of Iowa Research Foundation | Vaccine and method for preventing biofilm formation |
| WO2004072094A2 (en) * | 2003-02-14 | 2004-08-26 | Fondazione Centro San Raffaele Del Monte Tabor | Hmgb1 modulator binding domain |
| US7241867B2 (en) | 2003-03-06 | 2007-07-10 | Children's Hospital, Inc. | Polypeptide encoded by a nucleotide sequence of a nontypeable strain of Haemophilus influenzae genome |
| WO2005025604A2 (en) * | 2003-09-10 | 2005-03-24 | The General Hospital Corporation | Use of hmgb and hmgb fragments to decrease specific immune response |
| CN1934256A (zh) | 2004-03-26 | 2007-03-21 | 株式会社洛科摩基因 | 针对滑膜蛋白基因启动子的诱杀核酸 |
| US20080305120A1 (en) * | 2004-06-17 | 2008-12-11 | Medimmune, Inc. | Immunogenic Compositions Comprising Hmgb 1 Polypeptides |
| WO2006017816A2 (en) | 2004-08-06 | 2006-02-16 | National Jewish Medical And Research Center | Product and process for inhibition of biofilm development |
| JP2008520552A (ja) | 2004-10-22 | 2008-06-19 | メディミューン，インコーポレーテッド | Ｈｍｇｂ１に対する高親和性の抗体およびその使用法 |
| US20060228384A1 (en) | 2005-04-06 | 2006-10-12 | Sequoia Sciences, Inc. | Control of biofilm with a biofilm inhibitor |
| WO2006114805A2 (en) * | 2005-04-28 | 2006-11-02 | Fondazione Centro San Raffaele Del Monte Tabor | Use of hmgb2 and hmgb3 proteins for medical applications |
| US20090264342A1 (en) | 2006-02-13 | 2009-10-22 | Trustees Of Boston University | Compositions and methods for antibiotic potentiation and drug discovery |
| ES2497441T3 (es) | 2006-08-21 | 2014-09-22 | The University Of British Columbia | Péptidos inmunomoduladores catiónicos pequeños |
| EP1980269A1 (en) | 2007-04-13 | 2008-10-15 | Katholieke Universiteit Leuven | Prevention of staphylococcus biofilm formation |
| WO2011123396A1 (en) * | 2010-03-29 | 2011-10-06 | University Of Southern California | Compositions and methods for the removal of biofilms |
| JP6012603B2 (ja) * | 2010-09-09 | 2016-10-25 | ユニバーシティー オブ サザン カリフォルニア | バイオフィルムを除去するための組成物および方法 |
| EP3008088B1 (en) | 2013-06-13 | 2019-08-21 | Research Institute at Nationwide Children's Hospital | Compositions and methods for the treatment of burkholderia infections |
| US9745366B2 (en) | 2013-09-23 | 2017-08-29 | University Of Southern California | Compositions and methods for the prevention of microbial infections |
-
2011
- 2011-09-09 JP JP2013528356A patent/JP6012603B2/ja active Active
- 2011-09-09 EP EP11758346.8A patent/EP2613797B1/en active Active
- 2011-09-09 WO PCT/US2011/051107 patent/WO2012034090A1/en not_active Ceased
- 2011-09-09 CA CA2810851A patent/CA2810851C/en active Active
- 2011-09-09 US US13/229,575 patent/US20120128701A1/en not_active Abandoned
- 2011-09-09 AU AU2011299025A patent/AU2011299025B2/en active Active
-
2015
- 2015-09-30 JP JP2015193476A patent/JP2016000760A/ja not_active Withdrawn
- 2015-10-16 US US14/885,800 patent/US10595530B2/en active Active
-
2017
- 2017-06-22 JP JP2017122250A patent/JP6420417B2/ja active Active
-
2018
- 2018-04-20 JP JP2018081136A patent/JP2018111731A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018512454A5 (enExample) | ||
| BR0316082A (pt) | Métodos de tratar ou prevenir e de controlar uma doença mieloproliferative, de reduzir ou evitar um efeito adverso associado com a administração de um segundo agente ativo em um paciente sofrendo de uma doença mieloproliferativa e de aumentar a eficácia terapêutica de um tratamento de doenças mieloproliferativa, composição farmacêutica e kit | |
| BR0309837A (pt) | Forma de administração trans-epicutânea para tratamento da sìndrome das pernas inquietas | |
| BRPI0514420A (pt) | peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo | |
| JP2021504390A5 (enExample) | ||
| JP2015520188A5 (enExample) | ||
| BR112014027010A2 (pt) | uso de laquinimod de alta dose para tratamento de esclerose múltipla | |
| JP2017526627A5 (enExample) | ||
| JP2015514778A5 (enExample) | ||
| JP4234439B2 (ja) | Ｉｌ−１２発現調節剤 | |
| BR112014004587A2 (pt) | combinações sinérgicas de inibidores de pi3k- e de mek | |
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| WO2006078424A3 (en) | Polyherbal compositions and methods for treating viral infections | |
| ATE399562T1 (de) | Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen | |
| WO2010023195A3 (en) | Compositions and methods for treating cancer | |
| Krämer et al. | Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations | |
| TWI351950B (en) | Use of (halobenzyloxy) benzylamino-propanamides fo | |
| AR127533A1 (es) | INHIBIDORES DEL SARS-CoV-2 PARA EL TRATAMIENTO DE INFECCIONES POR CORONAVIRUS | |
| JP2016196419A (ja) | 皮膚外用製剤 | |
| JP2009500045A5 (enExample) | ||
| Liu et al. | Therapeutic effects of GDF6-overexpressing mesenchymal stem cells through upregulation of the GDF15/SIRT1 Axis in age-related hearing loss | |
| JP2014517038A5 (enExample) | ||
| Cheon et al. | Treatment of nail lichen Striatus with Intralesional steroid injection: A case report and literature review. | |
| Omar et al. | Tumor potential in rat wounds after short-and long-term administration of platelet-rich plasma | |
| JP2025503251A5 (enExample) |